| Financial Year |
March 31 2023 |
| Monetary Funds |
21,767,335,605.73 |
| Held-for-trading Financial Assets |
2,567,095,524.92 |
| Notes Receivable |
7,071,874,870.52 |
| Accounts Receivable |
15,796,431,635.41 |
| Advances to Suppliers |
9,057,870,960.00 |
| Other Receivables |
1,973,224,055.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,000,000.00 |
| Inventories |
53,326,552,436.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
396,659,434.30 |
| Other Current Assets |
48,633,608,949.57 |
| Total Current Assets |
173,338,813,204.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
832,053,100.97 |
| Long-term Equity Investment |
27,773,857,070.46 |
| Investment Properties |
561,946,500.88 |
| Fixed Assetes |
150,528,110,225.60 |
| Under-construction Projects |
12,061,430,550.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,994,028,169.74 |
| R&D expenses |
-- |
| Goodwill |
534,772,978.72 |
| Long-Term Deferred and Prepaid Expenses |
2,214,468,156.82 |
| Deferred Income Tax Assets |
3,613,959,571.15 |
| Other Non-Current Assets |
1,210,997,874.01 |
| Sub-Total of Non-Current Assets |
220,235,883,338.18 |
| Total Assets |
393,574,696,542.80 |
| Short-Term Loans |
4,137,650,744.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,749,217,720.11 |
| Accounts Payable |
55,246,783,506.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,708,936,058.27 |
| Taxes Payable |
1,298,166,902.23 |
| Interest Payable |
-- |
| Dividend Payable |
14,804,343.05 |
| Other payables |
3,503,513,697.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,704,953,069.61 |
| Other Current Liabilities |
2,673,624,966.88 |
| Sub-Total of Current Liabilities |
135,554,586,963.26 |
| Long-term Loans |
26,162,822,138.38 |
| Bonds Payable |
2,500,000,000.00 |
| Long-Term Accounts Payable |
2,043,591,366.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,483,793,007.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,873,446,492.74 |
| Total Liabilities |
175,428,033,456.00 |
| Paid-In Capital(Or Share Stock) |
22,262,200,234.00 |
| Capital Surplus |
50,192,986,540.45 |
| Surplus Reserve |
41,064,043,384.80 |
| LESS:Treasury Stock |
2,407,729,723.00 |
| Undistributed Profits |
85,850,478,711.51 |
| Minority Stockholder's Interest |
21,616,879,216.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
196,529,783,870.10 |
| Owner's Equity（Stockholder's Equity） |
218,146,663,086.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
393,574,696,542.80 |
